Central nervous pain in patients with spinal cord injury. Medical and operative therapy;Sentral neurogen smerte ved traumatisk ryggmargsskade. Medikamentell og kirurgisk behandling

Tidsskrift for den Norske Laegeforening

Volumn 117, Issue 13, 1997, Pages 1904-1907

  Grønning, Marit ^a   Ertzgaard, Per ^b   Myrseth, Erling ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BACLOFEN; CARBAMAZEPINE; DEXTROPROPOXYPHENE; KETOBEMIDONE; MORPHINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; HUMAN; MALE; PAIN; PARAPLEGIA; SPINAL CORD INJURY;

ANALGESICS; HUMANS; MALE; MIDDLE AGED; PAIN; SPINAL CORD; SPINAL CORD INJURIES;

EID: 0030957011     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Gjone R, Nordlie L. Incidence of traumatic paraplegia and tetraplegia in Norway: a statistical survey of the years 1974 and 1975. Paraplegia 1978; 16: 88-93.
2. Vården av ryggmärgsskadade. Rapport från en arbetsgrupp. Artikelnummer 1992-00-46. Stockholm: Socialstyrelsen, 1992.
3. Go BK, DeVivo MJ, Richards JS. The epidemiology of spinal cord injury. I: Stover SL, DeLisa JA, Whiteneck GG, red. Spinal cord injury. Clinical outcomes from the model systems. Gaithersburg, MD: Aspen Publishers, 1995: 21-55.
4. DeVivo MJ, Stover SL. Long-term survival and causes of death. I: Stover SL, DeLisa JA, Whiteneck GG, red. Spinal cord injury. Clinical outcomes from the model systems. Gaithersburg, MD: Aspen Publishers, 1995: 289-316.
5. Kaplan LI, Grynbaum BB, Lloyd KE, Rusk HA. Pain and spastisity in patients with spinal cord dysfunction. JAMA 1962; 182: 918-25.
6. Frisbie JH, Aguilera EJ. Chronic pain after spinal cord injury: an expedient diagnostic approach. Paraplegia 1990; 28: 460-5.
7. Daverat P, Petit H, Kemoun G, Dartigues JF, Barat M. The long term outcome in 149 patients with spinal cord injury. Paraplegia 1995; 33: 665-8.
8. Nepomuceno C, Fine PR, Richards JS, Gowens H, Stover SL, Rantanuabol U et al. Pain in patients with spinal cord injury. Arch Phys Med Rehabil 1979; 60: 605-9.
9. Anke AGW, Stenehjem AE, Stanghelle JK. Pain and life quality within 2 years of spinal cord injury. Paraplegia 1995; 33: 555-9.
10. Levi R, Hultling C, Nash MS, Seiger Å. The Stockholm spinal cord injury system: 1. Medical problems in a regional SCI population. Paraplegia 1995; 33: 308-15.
11. Task Force on Taxonomy of the International Association for the study of pain. Central pain. I: Merskey H, Bogduk N, red. Classification of chronic pain. Descriptions of chronic pain syndromes and definition of pain terms. Seattle: IASP press, 1994: 43-44.
12. Levi R, Hultling C, Seiger Å. The Stockholm spinal cord injury study: 2. Associations between clinical patient characteristics and post-acute medical problems. Paraplegia 1995; 33: 585-94.
13. Britell CW, Mariano AJ. Chronic pain in spinal cord injury. Phys Med Rehabil 1991; 5: 71-82.
14. Sie IH, Waters RL, Adkins RH, Gellman H. Upper extremity pain in the postrehabilitation spinal cord injured patient. Arch Phys Med Rehabil 1992; 73: 44-8.
15. Nashold BS. Paraplegia and pain. I: Nashold BS, Orelmen-Levitt J, red. Deafferentation pain syndromes. Pathophysiology and treatment. New York: Raven Press, 1991: 301-19.
16. Davies S, Illis LS, Raisman G. Regeneration in the central nervous system and related factors. Summary of the Bermuda Paraplegia Conference, April 1994 (International Spinal Researsh Trust). Paraplegia 1995; 33: 10-7.
17. Dubner R. Spinal cord neuronal plasticity: mechanisms of persistent pain following tissue damage and nerve injury. I: Vecchiet L, Albe-Fessard D, Lindblom U, Giamberardino, red. New trend in referred pain and hyperalgesia. Amsterdam: Elsevier, 1993: 109-17.
18. Beric A, Dimitrijevic, Lindblom U. Central dysesthesia syndrome in spinal cord injury patients. Pain 1988; 34: 109-16.
19. Ma W, Peschanski M, Ralstone III HJ. The differential synaptic organization of the spinal and lemniscal projections to the ventrobasal complex of the rat thalamus. Evidence for convergence of the two systems upon single thalamic neurons. Neuroscience 1978; 22: 925-34.
20. Lenz FA. The thalamus and central pain syndromes: human and animal studies. I: Casey KL, red. Pain and central nervous system disease: The central pain syndromes. New York: Raven Press, 1991: 171-82.
21. Loeser JD, Ward AA jr. Some effects of deafferentation of neurons of the cat spinal cord. Arch Neurol 1967; 17: 629-36.
22. Edgar RE, Best LG, Quail PA, Obert AD. Computer-assisted DREZ microcoagulation: posttraumatic spinal deafferentation pain. J Spinal Disord 1993; 6: 48-56.
23. Leijon G, Boivie J. Pharmacological treatment of central pain. I: Casey KL, red. Pain and central nervous system disease: the central pain syndromes. New York: Raven Press, 1991: 257-66.
24. Glynn CJ, Jamous MA, Teddy PJ, Moore RA. Role of spinal noradrenergic system in transmission of pain in patients with spinal cord injury. Lancet 1986; 29: 1249-50.
25. Fenollosa P, Pallares J, Cervera J, Pelegrin F, Inigo V, Giner M et al. Chronic pain in the spinal cord injured: statistical approach and pharmacological treatment. Paraplegia 1993; 31: 722-9.
26. Sørensen J, Bengtsson A, Bäckman E, Henriksson KG, Bengtsson M. Pain analysis in patients with fibromyalgia. Scand J Rheumatol 1995; 24: 360-5.
27. Park KM, Mitchell MB, Roinovitch E, Richard GH, Gary BJ. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia and allodynia produced by intradermal capsaicin in human subjects. Pain 1995; 63: 163-72.
28. Ebert B, Andersen S, Hjeds H, Dickenson. Commercially available opiate analgesics as non competitive NMDA antagonists. Neurosci Lett 1995; 187: 165-8.
29. Nagy I, Woolf CJ. Lignocain selectively reduces C fibre-evoked neuronal activity in rat spinal cord invitro by decreasing N-methyl-D-aspartate and neurokinin receptro-mediated post-synaptic depolarizations: implications for the development of novel centrally acting analgesics. Pain 1996; 64: 59-70.
30. Herman RM, D'Luzansky SC, Ippolito R. Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clin J Pain 1992; 8: 338-45.
31. Butler S. Present status of tricyclic antidepressants in chronic pain therapy. 1: Benedetti C, Chapman CR, Morrica G, red. Recent advances in the management of pain. Advances in pain research and therapy. VII. New York: Raven Press, 1984: 173-97.
32. Leijon G, Boivie J. Central post-stroke pain - a controlled trial of amitryptiline and carbamazepine. Pain 1989; 36: 27-36.
33. Sattenthwaite JR. Medical-management of postherpetic neuralgia. A review. Pain Management 1989; 2: 10-9.
34. Davis EH. Clinical trials of tegretol in trigeminal neuralgia. Headache 1969; 9: 77-82.
35. Gibson JC, White LE jr. Denervation hyperpathia: a convulsive syndrome of the spinal chord response to carbamazepine therapy. J Neurosurg 1971; 35: 287-91.
36. Sindou M. Microsurgical DREZotomy (MDT) for pain, spastisity, and hyperactive bladder: a 20-year experience. Acta Neurochir 1995; 137: 1-5.
37. Sampson JH, Cashman RE, Nashold BS, Friedman AH. Dorsal root entry zone lesions for intractable pain after trauma to the conus medullaris and cauda equina. J Neurosurg 1995; 82: 28-34.
38. Samii M, Moringlane JR. Thermocoagulation of the dorsal root entry zone for the treatment of intractable pain. Neurosurg 1984; 15: 953-5.
39. Richter HP, Seitz K. Dorsal root entry zone lesions for the control of deafferentation pain: experiences in ten patients. Neurosurg 1984; 15: 956-9.